Company Profiles

driven by the PitchBook Platform

Xeltis

Xeltis
2006 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$32.7M LATEST DEAL AMOUNT
$32.7M TOTAL AMOUNT RAISED
Description

Developer of synthetic biodegradable heart valves and blood vessels. The company manufactures and develops fully bioabsorbable synthetic heart valves and vascular grafts that enable the patient's own body to naturally form a new heart valve through a therapeutic approach called Endogenous Tissue Restoration. With ETR, the patient's natural healing system develops tissue that pervades Xeltis' heart valve, forming a new, natural and fully functional valve within it. As ETR occurs, Xeltis implants are gradually absorbed by the body.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Surgical Devices
Primary Office
Seefeldstrasse 35
8008 Zurich
Switzerland

+41 (0)44 269 7979
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xeltis’s full profile, request a free trial.

Xeltis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 17-Dec-2015 $32.7M $32.7M Completed Generating Revenue
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Xeltis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Kurma Partners Venture Capital Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
Mamie Capital Venture Capital Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0

You’re viewing 5 of 5 investors.

Xeltis Executive Team (27)

Name Title Board
Seat
Contact
Info
Laurent Grandidier Chief Executive Officer & Board Member
Boris Warnack Chief Operating Officer
Martijn Cox Ph.D Chief Technology Officer & Co-Founder
Eliane Schutte Chief Development Officer
Hugo Ploegmakers Manager Production and Supplier Quality
You’re viewing 5 of 27 executives. Get the full list »

Xeltis Board Members (7)

Name Representing Role Since Contact
Info
Christian Wenger Ph.D Self Board Member 000 0000
Clemens Van Blitterswijk Ph.D Life Sciences Partners Board Member 000 0000
Guillaume Connan Self Board Member 000 0000
Laurent Grandidier Xeltis Chief Executive Officer & Board Member 000 0000
Michael Colson Self Chairman of the Scientific Advisory Board 000 0000
You’re viewing 5 of 7 board members. Get the full list »